Recommended For You

Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.

JONS is delighted to announce this new department to offer thought-provoking insights, address the impact of various forces in our culture on navigation, and reaffirm of the importance of navigation programs.

At the heart of the Oncology Medical Home is triage, according to Barbara L. McAneny, MD, a board certified medical oncologist at New Mexico Oncology Hematology Consultants, and founder of Innovative Oncology Business Solutions (IOBS).

In this interview, members of The Urology Group discussed the importance of bone health in patients with prostate cancer, including details about the guidelines they use, the impact of prevention, as well as the different therapies they use in their practice.